Your AI-Trained Oncology Knowledge Connection!

Opinion

Video

Patient Profile 2: Patient Progression After Frontline HCC Therapy

Drs Saeed and Shroff discuss the next patient profile, focusing on HCC treatment strategies following disease progression after first-line therapy.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Subscribe Now!
Related Videos
Sheela Rao, MBBS, MD, FRCP
4 experts are featured in this series.
Richard T. Lee, MD, Cherng Family Director’s Chair, Center for Integrative Oncology, medical director, clinical professor, Supportive & Integrative Medicine, Department of Supportive Care Medicine, City of Hope
Rachna T. Shroff, MD, MS
Daneng Li, MD, associate professor, Department of Medical Oncology & Therapeutics Research, and co-director, Neuroendocrine Tumor Program, City of Hope
Related Content
Sheela Rao, MBBS, MD, FRCP
March 21st 2025

Improving Outcomes for Patients With Anal Cancer By Raising Awareness

OncLive On Air
September 11th 2024

Oncology Experts Preview Top Abstracts From the 2024 ESMO Congress

FDA
March 19th 2025

FDA Approves Pembrolizumab Plus Trastuzumab/Chemo for PD-L1+, HER2+ Gastric/GEJ Adenocarcinoma

Stephen Liu, MD; Sara A. Hurvitz, MD, FACP; S. Vincent Rajkumar, MD; Sumanta Kumar Pal, MD, FASCO; Shubham Pant, MD, MBBS
May 23rd 2024

Oncology Experts Preview Top Abstracts From the 2024 ASCO Annual Meeting

Aditya Shreenivas, MD, MS
March 19th 2025

Association Between CLDN18 and MUC1 Could Drive Novel Targeted Therapy Options in GI Cancers

Ajay Goel, PhD, AGAF, professor, chair, Department of Molecular Diagnostics and Experimental Therapeutics at City of Hope in Duarte, California
March 19th 2025

CA19-9 Plus Liquid Biopsy Represents Diagnostic Biomarker of Interest for Early-Stage Pancreatic Cancer Detection